TY - JOUR
T1 - Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer
AU - Wagner, Jamie
AU - Boughey, Judy C.
AU - Garrett, Betsy
AU - Babiera, Gildy
AU - Kuerer, Henry
AU - Meric-Bernstam, Funda
AU - Singletary, Eva
AU - Hunt, Kelly K.
AU - Middleton, Lavinia P.
AU - Bedrosian, Isabelle
PY - 2009/9
Y1 - 2009/9
N2 - Background: Optimal surgical management of patients with invasive lobular carcinoma (ILC) who undergo neoadjuvant chemotherapy (NAC) is unknown. We evaluated optimal margin distance and local recurrence (LR) rates for these patients. Methods: Ninety-three (30%) of 311 patients with ILC received NAC. We examined margin status, residual disease after re-excision, and clinical outcomes. Results: Margin positivity rates after the final operative procedure were similar between the NAC and surgery-first group (P > .05). The proportion of patients, stratified by margin status, who were taken back for re-excision was not different between the 2 groups, and, similarly, there were no differences in frequency of residual disease (all P > .05). At a median follow-up of 3.1 years, 1 patient in the NAC group and 2 in the surgery-first group developed LR (P = 1.0). Conclusions: Patients with ILC who have undergone NAC and have margins >1 mm have a low probability of residual disease and LR.
AB - Background: Optimal surgical management of patients with invasive lobular carcinoma (ILC) who undergo neoadjuvant chemotherapy (NAC) is unknown. We evaluated optimal margin distance and local recurrence (LR) rates for these patients. Methods: Ninety-three (30%) of 311 patients with ILC received NAC. We examined margin status, residual disease after re-excision, and clinical outcomes. Results: Margin positivity rates after the final operative procedure were similar between the NAC and surgery-first group (P > .05). The proportion of patients, stratified by margin status, who were taken back for re-excision was not different between the 2 groups, and, similarly, there were no differences in frequency of residual disease (all P > .05). At a median follow-up of 3.1 years, 1 patient in the NAC group and 2 in the surgery-first group developed LR (P = 1.0). Conclusions: Patients with ILC who have undergone NAC and have margins >1 mm have a low probability of residual disease and LR.
KW - Breast
KW - Lobular cancer
KW - Local recurrence
KW - Margins
KW - Neoadjuvant chemotherapy
UR - http://www.scopus.com/inward/record.url?scp=67349220534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67349220534&partnerID=8YFLogxK
U2 - 10.1016/j.amjsurg.2009.01.006
DO - 10.1016/j.amjsurg.2009.01.006
M3 - Article
C2 - 19362281
AN - SCOPUS:67349220534
SN - 0002-9610
VL - 198
SP - 387
EP - 391
JO - American Journal of Surgery
JF - American Journal of Surgery
IS - 3
ER -